公开(公告)号：EP2654770B1

公开(公告)日：2018-07-11

申请号：EP11851346.4

申请日：2011-12-16

申请人： Gennova Biopharmaceuticals Ltd.

发明人： SINGH, Sanjay ,  MISHRA, Maheshwari Kumar ,  BHANDARI, Pritiranjan

IPC分类号： A61K38/16 ,  A61K9/16 ,  A61P9/10

CPC分类号： A61K38/482 ,  A61K9/0019 ,  A61K9/19 ,  A61K47/02 ,  A61K47/183 ,  A61K47/26 ,  C12Y304/21068

摘要： Pharmaceutical compositions of tenecteplase that are safe and effective in the treatment of acute ischemic stroke compared with the known compositions are disclosed. The compositions of the invention are invented based on a series of testing trials on the different amounts of the TNK and isolating specific amount that is optimally suitable in terms of desired effects of TNK in the treatment of acute ischemic stroke.

公开(公告)号：EP2654770A1

公开(公告)日：2013-10-30

申请号：EP11851346.4

申请日：2011-12-16

申请人： Gennova Biopharmaceuticals Ltd.

发明人： SINGH, Sanjay ,  MISHRA, Maheshwari Kumar ,  BHANDARI, Pritiranjan

IPC分类号： A61K38/16 ,  A61K9/16 ,  A61P9/10

CPC分类号： A61K38/482 ,  A61K9/0019 ,  A61K9/19 ,  A61K47/02 ,  A61K47/183 ,  A61K47/26 ,  C12Y304/21068

摘要： Pharmaceutical compositions of tenecteplase that are safe and effective in the treatment of acute ischemic stroke compared with the known compositions are disclosed. The compositions of the invention are invented based on a series of testing trials on the different amounts of the TNK and isolating specific amount that is optimally suitable in terms of desired effects of TNK in the treatment of acute ischemic stroke.